Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Cholestasis

ribavirin has been researched along with Cholestasis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botta, D; Coilly, A; D'Alteroche, L; Diallo, A; Duclos-Vallee, JC; Dumortier, J; Durand, F; Fougerou-Leurent, C; Houssel-Debry, P; Kamar, N; Lebray, P; Leroy, V; Pageaux, GP; Petrov-Sanchez, V; Radenne, S; Sebagh, M; Silvain, C1
Ishiguro, M; Kamio, Y; Mori, N; Murakami, T; Shimomukai, Y; Yokooji, T1
Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA1
Gopal, DV; Rosen, HR1
Kakizaki, S; Mori, M; Sato, K; Sohara, N; Takagi, H1
Buffet, C1
Forţofoiu, C; Genunche, A; Gofiţă, E; Streba, LA; Vere, CC1
Goodman, Z; Gramlich, T; Mayes, J; Ong, JP; Sarbah, S; Yen-Lieberman, B; Younossi, ZM1

Reviews

1 review(s) available for ribavirin and Cholestasis

ArticleYear
[Acute hepatitis. Biological hepatic anomalies in asymptomatic persons].
    La Revue du praticien, 2006, Sep-15, Volume: 56, Issue:13

    Topics: Acute Disease; Adult; Antiviral Agents; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Diagnosis, Differential; France; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Hepatitis D; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Phosphoric Monoester Hydrolases; Prevalence; Ribavirin; Transaminases

2006

Trials

1 trial(s) available for ribavirin and Cholestasis

ArticleYear
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, Volume: 13, Issue:11

    Topics: Antiviral Agents; Belgium; Carbamates; Cholestasis; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; France; Hepatitis C; Humans; Imidazoles; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine

2015

Other Studies

6 other study(ies) available for ribavirin and Cholestasis

ArticleYear
Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats.
    Die Pharmazie, 2011, Volume: 66, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Bile; Biological Availability; Cephalexin; Cholestasis; Chromatography, High Pressure Liquid; Deoxycytidine; Gemcitabine; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Intestinal Absorption; Lipopolysaccharides; Male; Nucleoside Transport Proteins; Rats; Rats, Sprague-Dawley; Ribavirin; Ribonucleosides

2011
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2012, Volume: 18, Issue:9

    Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Reoperation; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Valine; Viral Load

2012
Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2003, Volume: 9, Issue:4

    Topics: Antiviral Agents; Bilirubin; Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Remission Induction; Ribavirin; RNA, Viral; Viremia

2003
The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia.
    Transplant international : official journal of the European Society for Organ Transplantation, 2006, Volume: 19, Issue:3

    Topics: Antiviral Agents; Cholestasis; Embolization, Therapeutic; Female; Hepatitis C; Humans; Interferons; Liver Transplantation; Middle Aged; Ribavirin; Splenectomy; Splenic Artery; Thrombocytopenia

2006
Antiviral therapy effects upon hepatitis C cholestatic syndrome.
    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2007, Volume: 48, Issue:1

    Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Cholestasis; Cholesterol; Drug Therapy, Combination; gamma-Glutamyltransferase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leucyl Aminopeptidase; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Syndrome

2007
Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C.
    Transplantation, 2001, May-27, Volume: 71, Issue:10

    Topics: Adult; Antiviral Agents; Cholestasis; Drug Therapy, Combination; Fatal Outcome; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Severity of Illness Index

2001